Pain Reduction in Maxillomandibular Surgery Using Maxillary and Mandibular Nerve Blocks
- Conditions
- Regional AnesthesiaPain, Post Operative
- Interventions
- Procedure: bilateral ultra-sound guided maxillary and mandibular nerve blocksProcedure: Infiltration of Lidocaine 1%
- Registration Number
- NCT05351151
- Lead Sponsor
- University Hospital, Toulouse
- Brief Summary
Maxillo-mandibular osteotomy is a painful surgery which requires mostly opioids use. Recent studies on maxillary and mandibular nerve blocks have suggested benefit in maxillo-facial surgery but have been poorly investigated in orthognathic surgery. This study is designed to evaluate analgesic effectiveness, through opioids consumption, of a bilateral double ultra-sound guided nerve blocks (maxillar and mandibular nerve) in maxillo-mandibular osteotomy.
- Detailed Description
Maxillo-mandibular osteotomy is a frequent but painful procedure in maxillo-facial surgery. It mostly requires opioids use which lead to well known side effects. Regional anesthesia has strongly modified post-surgical rehabilitation of many procedures. Maxillary nerve block has proved its efficiency on opioid consumption reduction in pediatric cleft palet surgery but has been rarely evaluated in orthognathic surgery. Mandibular nerve block has never been investigated in maxillo-mandibular osteotomy as well as benefit of bilateral ultra-sound guided technique to perform these nerve blocks. Consequently, this trial is designed to evaluate analgesic effectiveness of a double ultra-sound guided nerve blocks (maxillar and mandibular nerve) in maxillo-mandibular osteotomy.
This monocentric, single-blinded, randomized controled trial is designed with 2 groups of 25 patients receiving either bilateral double ultra-sound guided nerve block (maxillary and mandibular) with ROPIVACAINE 4.75mg/mL either local infiltration of LIDOCAINE 1% at incision sites by surgeon after general anesthesia induction during maxillo-mandibular osteotomy. Per et post-surgery anesthesic protocol and analgesia are standardized for both group. The main outcome corresponds to opioid consumption in MME of the first 24h after surgery. Follow-up occurs at 24h and 48h after end of surgery to assess analgesia, pain and opioid consumption.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Patients from 15 to 45 years old,
- Scheduled for maxillary-mandibular osteotomy,
- Registered in French social insurance register,
- With informed consent disclosure.
- American Society of Anesthesiologists (ASA) classification ≥ 3
- Innate or acquired hemostasis pathology,
- Peripheric neuropathy,
- Drug intake for chronic pain,
- Infection/scar at needle insertion site,
- Associated rhinoplasty surgery,
- Allergy to local anesthetics,
- Pregnant woman or potentially,
- Breastfeeding woman,
- Already registered in other clinical trial,
- Adults under legal protection of incapable adult,
- Cognitive disease impairing using of evaluation tools performed in protocol,
- All contraindication of anesthetics drugs used in protocol.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Loco Regional anesthesia (LRA) bilateral ultra-sound guided maxillary and mandibular nerve blocks The LRA group is made up of patients benefiting from the V2 and V3 ultrasound-guided LRA technique without mucosal infiltration. Infiltration Infiltration of Lidocaine 1% The "Infiltration" group is made up of patients who benefit from the infiltration technique by local anesthesia of the incision sites by the surgeon without recourse to ultrasound-guided LRA.
- Primary Outcome Measures
Name Time Method The opioid consumption (in Morphine Milligram Equivalents) after the first 24 hours post-surgery. 24 hours post-surgery The opioid consumption (in Morphine Milligram Equivalents ) after the first 24hours post-surgery.
- Secondary Outcome Measures
Name Time Method Maximal pain (Numerical Rating Scale) in recovery room, at 24h after surgery. 24 hours after surgery Pain assessment by Simple Numerical Scale (ENS from 0 to 10) in the Postoperative Monitoring Room (maximum value) at the 24th postoperative hour
Maximal pain (Numerical Rating Scale) in recovery room, at 48 hours after surgery. 48 hours after surgery Pain assessment by Simple Numerical Scale (ENS from 0 to 10) in the Postoperative Monitoring Room (maximum value) at the 48th postoperative hour.
Evaluation of preoperative anxiety and fear using Amsterdam Preoperative Anxiety and Information Scale on post-surgical pain pré-anesthesic visit (day -1 or day 0) The patient's degree of pre-operative anxiety will be assessed using the Amsterdam Preoperative Anxiety and Information questionnaire in French Items are rated on a 5-point Likert scale ranging from 1 = "not at all" to 5 = "extremely"
Opioid consumption in Morphine Milligram Equivalents after the first 48 hours post-surgery. 48 hours post-surgery Evaluation of the total consumption of morphine equivalents (Oxycodone Hydrochloride) after the first 48 hours postoperative hour.
Incidence of opioid-Emergent Adverse Events [Safety and Tolerability] 3 days Measuring the incidence rate of common side effects associated with morphine drugs
Evaluation of patient satisfaction about medical care 3 days (maximum) The patient's feelings and satisfaction with their care will be evaluated by completing the questionnaire The feeling and satisfaction is rated according to a scale of 5 categories as follows: None, Low, Medium, High and Very High
Incidence of regional anesthesia-Emergent Adverse Event [Safety and Tolerability] 3 days Measuring the incidence rate of common side effects associated with regional anesthesia
Trial Locations
- Locations (1)
University Hospital of Toulouse
🇫🇷Toulouse, France